August 1, 2025
Title: Vaccine value assessment
Abstract
Vaccine value can be assessed from multiple perspectives, including health benefits, safety, economic impact, equity, acceptance, feasibility, antimicrobial resistance, and broader socio-economic benefits. In the first half, I will present specific case studies in the context of HPV, chikungunya, typhoid and Nipah vaccines, and antimicrobial resistance. In the second half, we will discuss related research and education opportunities for potential collaborations with NDMC.